glp-1 ketosis Synergistic Effects of the Ketogenic Diet and Weight Loss Medications Keto and GLP-1: combining ketogenic
Description
The landscape of medical weight loss has just shifted dramatically
Our editors independently choose our recommendations
The SELECT clinical trial results found a statistically significant drop among trial subjects taking a GLP-1 in hospitalizations and surgeries considered serious adverse events
FDA Drug Safety Communication: FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin
Consent for publication All authors have reviewed and approved the manuscript for publication
Substantial variability emerged among individual agents: exenatide demonstrated the longest median latency (54 days, IQR 16184), while dulaglutide showed the shortest (7 days, IQR 234)
